Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2022-07-05 00:00:00 ET · period of report 2022-07-01 · accession 0000880984-22-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-07-05 | 2022-07-01 | NRXP | Javitt Daniel C. | 10% | G - Gift | $0.00 | -2.00M | 10.66M | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | G | D | 2,000,000 | $0.00 | 10,656,964 | I by Glytech LLC | — | — | (F1) Shares were gifted to a charitable remainder unitrust. (F2) Held by Glytech LLC of which the Reporting Person is the sole owner. |